Article | October 22, 2020

Commercial Vaccine Manufacturing - How To Prepare For The Rapid Set-Up?

Source: Sartorius

By Amélie Boulais, Vaccine Platform Marketing Manager, and Piergiuseppe Nestola, Global Vaccine Technology Consultant

Syringe vaccine

A typical vaccine takes around 10 to 12 years to reach the market, giving developers ample time to consider strategies for mass manufacture. A key question: “Where should we base production?”

A company may plan to build a dedicated manufacturing facility in anticipation of a potential blockbuster (a risky approach – the vaccine could fail in phase III), or may decide to launch the vaccine out of the pilot facility.

Some vaccine manufacturers are now considering the use of flexible facilities that can accommodate the manufacturing of different vaccine types, depending on the demand, which is a challenge given the variability of current legacy vaccine processes.

Learn more about recommendations on how to prepare for the rapid set-up of commercial vaccine manufacturing.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online